Dow Decision to Delay R&H Deal Could Trigger Expensive Legal Battle (Update 2)

Dow Chemical’s CEO Andrew Liveris has defended his company’s decision not to close the previously announced $18.7 billion deal, including $3.7 billion of R&H debt, to acquire Rohm & Haas (R&H) by close of January 27. He told CNBC Tuesday that “conditions have deteriorated very significantly” since the deal was announced and that combining R&H with Dow right now would be bad for both companies. But he said he did not blame R&H for going to court. R&H asked a Delaware court on January 26 to force Dow to complete the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers